Next Article in Journal
Colorectal Cancer Patients’ Reported Frequency, Content, and Satisfaction with Advance Care Planning Discussions
Previous Article in Journal
The Role of Adjuvant Radiotherapy in the Treatment of Breast Cancer
 
 
Article
Peer-Review Record

Modeling 5-FU-Induced Chemotherapy Selection of a Drug-Resistant Cancer Stem Cell Subpopulation

Curr. Oncol. 2024, 31(3), 1221-1234; https://doi.org/10.3390/curroncol31030091
by Amra Ramović Hamzagić 1,2, Danijela Cvetković 1,2,*, Marina Gazdić Janković 1,2, Nevena Milivojević Dimitrijević 3, Dalibor Nikolić 3,4, Marko Živanović 3, Nikolina Kastratović 1,2, Ivica Petrović 5, Sandra Nikolić 1,2, Milena Jovanović 6, Dragana Šeklić 3, Nenad Filipović 4,7 and Biljana Ljujić 1,2
Reviewer 1:
Reviewer 2:
Curr. Oncol. 2024, 31(3), 1221-1234; https://doi.org/10.3390/curroncol31030091
Submission received: 23 January 2024 / Revised: 16 February 2024 / Accepted: 22 February 2024 / Published: 25 February 2024

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

Hamzagic et al. describe in their manuscript about the investigation of the level of different CSC markers in various tumor cells after treatment with the well-known chemotherapeutic drug 5-FU. They compared these findings to the prediction of a genetic algorithm model, which found very similar predictions to their results. The manuscript is well-written, timely and highlights very important aspects, namely the possible resistance mechanisms of current chemotherapeutic treatments.

The title is too general and should be improved to specify the findings of the study.   I suggest including the term 5-FU in the new title.

Figure 3. control bars have no SD.

Please specify in the methods that the cell lines are of human origin.

In figure 3. The control values go up from around 20 to 50 percent, it shows that even control cells started cell death for some reason. Can you explain the reason to it?

Values of control data increased over incubation time in other experiments as well (Fig 2., 7.), Percentage of (A) CD24-CD44+, 204 (B) ALDH1+ and (C) CD24-ABCG2+ALDH1+ tumor cells untreated. Can you explain the reason to it?

CD133 was not tested on HCT-166 cells, can you explain why.

Comments on the Quality of English Language

Quality of English language of the manuscript is fine. 

Author Response

Please find the attached file

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

Please find the attached file

Comments for author File: Comments.pdf

Comments on the Quality of English Language


Author Response

Please find the attached file

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

Comments and Suggestions for Authors

The authors have addressed all my concerns.

Back to TopTop